KRAS and pancreatic neoplasm: Therefore, the authors designed oligonucleotides that mimic one of the G-quadruplexes formed by NHE (G4-decoys), and found that the decoy strategy inhibits KRAS in pancreatic cancer cells and reduces tumor growth in human pancreatic cancer xenograft mice [112].